Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study Anum Shaikh; Gabriel Pedra; Leonardo Ruiz-Casas; Bethany Franks; Harpal Dhillon; João Diogo da Rocha Fernandes; Kamal Kant Mangla; Margarida Augusto; Manuel Romero-Gómez; Jörn M. Schattenberg;

Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-¿B signaling Yingwei Zhu; Hong Tang; Han Zhao; Jian Lu; Kai Lin; Jingbin Ni; Bo Zhao; Gaojue Wu; Chunxiao Tan;

Fibrosis avanzada asociada a esteatohepatitis no alcohólica (NASH) en España: resultados de un estudio Delphi Rocío Aller; José Luis Calleja; Javier Crespo; Manuel Romero-Gómez; Juan Turnes; Omar J. Benmarzouk-Hidalgo; Rafael Subirán; Alicia Gil;